Iron%252525252525252525252525252525252525252525252520sucrose

### Iron sucrose ## Overview Iron sucrose is an intravenous iron preparation used to treat iron deficiency anemia when oral iron is ineffective or not tolerated. It replenishes depleted iron stores. ## Primary Indications * Iron deficiency anemia in patients with chronic kidney disease (CKD) on hemodialysis or peritoneal dialysis. * Iron deficiency anemia in patients with CKD not on dialysis. * Iron deficiency anemia in non-dialysis CKD patients who are not tolerant of or who do not achieve sufficient hemoglobin response with oral iron. ## Adult Dosing The total cumulative dose depends on the degree of iron deficiency. A common regimen involves administering a total of 1000 mg over 10 dialysis sessions. This can be achieved by administering 100 mg (5 mL) per dialysis session. Alternative dosing regimens exist. For example, a single dose of 500 mg or 1000 mg may be given. Dosing should be individualized based on patient's iron status (ferritin, transferrin saturation) and clinical needs. Maximum single dose: 125 mg (6.25 mL). Maximum weekly dose: Not to exceed 300 mg (15 mL). Maximum cumulative dose: Varies, but often aims for 1000 mg to 2000 mg depending on baseline iron status. ## Pediatric Dosing Dosing in pediatric patients is less well-established and should be guided by specific protocols and expert consultation. Generally, doses are lower and depend on weight and age. For example, some protocols suggest 1.5 mg/kg per dose, not to exceed 100 mg per dose, given intravenously over 1 hour. The total cumulative dose is calculated based on estimated iron deficit. ## Dose Adjustments No specific dose adjustments are recommended for hepatic or renal impairment beyond the underlying condition's impact on iron metabolism and anemia. However, caution is advised in patients with active infection. ## Contraindications * Known hypersensitivity to iron sucrose or any of its excipients. * Iron overload. * Patients with anemia not due to iron deficiency. ## Adverse Effects * Hypersensitivity reactions (including anaphylaxis, which can be severe and life-threatening). * Hypotension. * Nausea, vomiting, diarrhea, constipation. * Headache, dizziness, fatigue. * Arthralgia, myalgia. * Injection site reactions (pain, swelling). * Dyspnea, chest pain. * Back pain. * Fever. ## Key Drug Interactions No significant drug interactions are expected with iron sucrose itself. However, concurrent administration with other intravenous medications should be avoided unless specifically indicated. Oral iron supplements should not be administered concurrently with IV iron sucrose as absorption may be impaired. ## Monitoring * Iron studies (serum ferritin, transferrin saturation) to assess iron repletion. * Hemoglobin or hematocrit to assess response. * Blood pressure, especially during and after infusion, due to risk of hypotension. * Signs and symptoms of hypersensitivity reactions. ## Clinical Pearls * Administer slowly to minimize the risk of hypotension and hypersensitivity reactions. * Always administer as a slow intravenous injection or infusion. Do not administer intramuscularly. * Observe patients for at least 15 minutes following administration due to the potential for immediate hypersensitivity reactions. * Iron sucrose can stain skin if extravasation occurs. * The color of the solution is dark brown. This information is intended for healthcare professionals. Always consult the most current prescribing information and local protocols for definitive guidance.